'Fibrinogen' diaporamas de présentation

Jasmeet K aur

Jasmeet K aur. Fluids and Transfusion SpR in Anaesthesia, RNOH. Blood Transfusion. Topics. Why? When? Who? Risks Massive Haemmorrhage. Example 1. A fit patient with a compound fracture of the tibia and a post operative Hb of 7.5 g/dl should be transfused?. Example 2.

700 views • 56 slides

Afibrinogenemia-Case Report

Afibrinogenemia-Case Report. Bijan Keikhaei, Ahvaz Jundishapur University of Medical Sciences. Case Presentation. A 14 Yr-old boy, was referred to the Shafa Hospital on Mehr 1392, for the Acute loss of consciousness.

597 views • 25 slides

Tests to measure fibrin clot

Tests to measure fibrin clot. General Approach in Investigation of Haemostasis. Lecture 9:. Tests to Measure Fibrin formation. Thrombin Time TT Reptilase Time Fibrinogen Activity assay. Thrombin Time (TT). Also Called Thrombin Clotting Time (TCT).

649 views • 24 slides

361 views • 23 slides

Introduction

Introduction. High fibrinogen is a risk factor for CVD Meta-analyses show a two times higher risk for each 1 g/L increase Fibrinogen is heterogeneous with different isoforms ? 90% contain only ? A chains ? 10% contain a ? ' chain. Introduction (cont).

300 views • 17 slides

U06- 22779

184 views • 10 slides

Human Fibrinogen Market: Asia Pacific has huge scope for growth and adoption through 2021

To Get sample Brochure now@ http://tinyurl.com/maksrhj A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Global Human Fibrinogen Market and future opportunities are provided in the report.

143 views • 6 slides

Clinical Relevance of Clot Selectivity

Clinical Relevance of Clot Selectivity. Action of Clot-Selective Agents. Action of Non-Clot-Selective Agents. (TNK-tPA, staphylokinase, t-PA). (r-PA, SK, n-PA, UK). Clot-selective Clot Blood vessel plasminogen activators. Non-clot-selective Clot Blood vessel plasminogen activators.

164 views • 5 slides

Clinical Relevance of Clot Selectivity

Clinical Relevance of Clot Selectivity. Action of Clot-Selective Agents. Action of Non-Clot-Selective Agents. (TNK-tPA, staphylokinase, t-PA). (r-PA, SK, n-PA, UK). Clot-selective Clot Blood vessel plasminogen activators. Non-clot-selective Clot Blood vessel plasminogen activators.

134 views • 5 slides

Clinical Relevance of Clot Selectivity

Clinical Relevance of Clot Selectivity. Action of Clot-Selective Agents. Action of Non-Clot-Selective Agents. (TNK-tPA, staphylokinase, t-PA). (r-PA, SK, n-PA, UK). Clot-selective Clot Blood vessel plasminogen activators. Non-clot-selective Clot Blood vessel plasminogen activators.

119 views • 5 slides

Fibrinogen Market Opportunistic Growth & Demand Analysis & Industry Forecasts 2018 to 2025

Global Fibrinogen Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are increasing across the globe. Fibrinogen (factor I) is a blood plasma protein which is synthesised by the liver. Fibrinogen is one of 13 coagulation factors in charge for normal blood clotting. In case of blood diseases, Fibrinogen Concentrate is used as a medicine. Fibrinogen concentrate is produced from pooled plasma. Fibrinogen Market is classified on the basis of geography as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan and Middle East and Africa.

60 views • 5 slides

Fibrinogen Market to Grow at a CAGR of 16.7% During the Forecast Period 2019-2023

The Global Fibrinogen Market is set to project at a CAGR of 16.7% during the forecast period. Development of novel delivery systems such as patches & sprays is stimulating the market growth. Fibrinogen plays an important role in the maintenance of homeostasis. In cases of acute blood loss, fibrinogen is the prime congealing factor to lessen the severity of blood flow. The fibrinogen market is driven by rise in distributor channels and networks across the globe. Increase in medical advances and availability of patient pools are likely to propel the market growth in the forecast period. Development of point-of-care diagnostic testing in developed and developing countries is likely to gain a significant CAGR in the forecast period. In addition, rise in incidences for using fibrinogen testing is likely to propel the market growth during the forecast period. Subsequently, increase in cancer cases and rise of market entrants have stimulated the market growth for long. End-user segmentation for fibrinogen market includes surgical procedures and congenital fibrinogen deficiency. Product segmentation for fibrinogen market includes human fibrinogen concentrate and animal fibrinogen concentrate.

35 views • 3 slides

Major Haemorrhage Management

Useful Contacts: Clinical Emergency 3333 Surgical SpR page 8600 Anaesthetic SpR page 8602 Blood Bank Ext 80393 or via switchboard Consultant Haematologist. CALL FOR HELP Check: A irway B reathing C irculation. Minimise bleeding Consider arterial or direct pressure.

600 views • 2 slides

Protein Fouling in Vascular Implants

Protein Fouling in Vascular Implants Madeline Lok, Matthew Rakochey, Gillian McKercher, Michael Mislan Schulich School of Engineering, University of Calgary. Group 18. Vascular Implants. Clot Formation.

170 views • 1 slides

Assessment of Cardiac Surgical Bleeding: TEG

Assessment of Cardiac Surgical Bleeding: TEG. Angle. Fibrinogen. R. K. MA. Bloodcmecenter.org. Platelets (75%) Fibrinogen (25%). INR + aPTT + Bleeding time. Courtesy of Mark Ereth , MD.

308 views • 1 slides